Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Advances in Drug Based Nanosystems for Cancer Therapy"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 February 2021) | Viewed by 9343
Special Issue Editor
Interests: drug delivery; drug carriers; nanomedicine; nanoparticles; gemini surfactants; biopolymers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Significant progress has been made in nanoscale drugs based on nanosystems employing diverse chemical formulations to facilitate the drug delivery and to improve its adsorption and therapeutic effect. Biocompatible nanomaterials have been used as pharmaceuticals, drug delivery systems, as well as in the treatment of various types of diseases. Nanotechnology especially has a significant impact in cancer research due to the possibility of controlled manipulation of material at the nanometer length scale, facile functionalization with different drugs, improved solubility, permeability, and targetability. Given the high toxicity of free anticancer drugs, it is relevant to search for nanocarriers that decrease the side effects of the drug and are able to transport it toward a therapeutic target. Furthermore, nanosystems for cancer applications allow manipulation of biopharmaceutical pharmacokinetics and pharmacodynamic drug properties. However, the rational design of new drug-based nanosystems requires the control and optimization of the physicochemical properties of the nanosystems, such as its particle size and charge, stability, and aggregation state of the system. Such optimization will lead to a more in-depth understanding of the structure‒effectivity relationship in the design of new drug-based nanoparticle materials for cancer treatment. This Special Issue serves to highlight new avenues of research and recent progress in the use of nanosystems as vehicles for the delivery of anticancer drugs and the effective control of its physicochemical properties for improving effectiveness.
Dr. Elia M. Grueso
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- drug carriers
- physicochemical properties